Safety and Efficacy of Long-Term Zoledronic Acid in Advanced Breast Cancer with Bone Metastasis in South China

Safety and Efficacy of Long-Term Zoledronic Acid in Advanced Breast Cancer with Bone Metastasis in South China

Background. This retrospective study aimed to characterize the long-term (>24 months) safety profile of zoledronic acid (ZA). We aimed to investigate whether long-term ZA treatment had greater benefits than short-term treatment in patients from southern China with advanced breast cancer (ABC) wit...

Full description

Bibliographic Details
Main Authors:	Qianyu Wang, Guifang Guo, Zhaohui Ruan, Huijiao Cao, Ying Guo, Long Bai, Chang Jiang, Shousheng Liu, Wenzhuo He, Jinsheng Huang, Yuming Rong, Xuxian Chen, Liangping Xia, Bei Zhang, Roujun Peng
Format:	Article
Language:	English
Published:	Hindawi Limited 2020-01-01
Series:	Journal of Oncology
Online Access:	http://dx.doi.org/10.1155/2020/5670601

Similar Items

Low-dose zoledronate for the treatment of bone metastasis secondary to prostate cancer
by: Elie Akoury, et al.
Published: (2019-02-01)

Bone-seeking nanoplatform co-delivering cisplatin and zoledronate for synergistic therapy of breast cancer bone metastasis and bone resorption
by: Yanjuan Huang, et al.
Published: (2020-12-01)

Various pathways of zoledronic acid against osteoclasts and bone cancer metastasis: a brief review
by: Lianwei Wang, et al.
Published: (2020-11-01)

Time associated with intravenous zoledronic acid administration in patients with breast or prostate cancer and bone metastasis
by: Richhariya A, et al.
Published: (2012-02-01)

Prognostic value of total number of lymph nodes retrieved differs between left-sided colon cancer and right-sided colon cancer in stage III patients with colon cancer
by: Lin Yang, et al.
Published: (2018-05-01)

Controlled delivery of zoledronate improved bone formation locally in vivo.
by: Wenlong Gou, et al.
Published: (2014-01-01)

Zoledronic acid in the management of metastatic bone disease
by: Thomas J Polascik, et al.
Published: (2008-03-01)

Endometrial Cancer Diagnosed by the Presence of Bone Metastasis and Treated with Zoledronic Acid: A Case Report and Review of the Literature
by: Aiko Shigemitsu, et al.
Published: (2010-12-01)

Natural history of stage II/III breast cancer, bone metastasis and the impact of adjuvant zoledronate on distribution of recurrences
by: Stella D'Oronzo, et al.
Published: (2021-06-01)

Zoledronic acid preserves bone structure and increases survival but does not limit tumour incidence in a prostate cancer bone metastasis model.
by: Tzong-Tyng Hung, et al.
Published: (2011-01-01)

Study of the inhibitory effects of Zoledronate on the metastasis and invasion of human osteosarcoma cells
by: Hsin-Lin Cheng, et al.
Published: (2016)

Establishment of inflammation biomarkers-based nomograms to predict prognosis of advanced colorectal cancer patients based on real world data.
by: Guifang Guo, et al.
Published: (2018-01-01)

Effect of intravenous administration of zoledronic acid on jaw bone density in cases having skeletal metastasis: A prospective clinical study
by: Veena Jain, et al.
Published: (2019-01-01)

The Effect of Zoledronate Pretreatment on BMP Induced Bone Formation in Mice
by: Prichert, Marina
Published: (2011)

The Effect of Zoledronate Pretreatment on BMP Induced Bone Formation in Mice
by: Prichert, Marina
Published: (2011)

The Effects of Zoledronate and Raloxifene Combination Therapy on Diseased Mouse Bone
by: Powell, Katherine M.
Published: (2019)

Bone metastasis pattern of cancer patients with bone metastasis but no visceral metastasis
by: Mingyu Zhu, et al.
Published: (2019-04-01)

Intra-tumor delivery of zoledronate mitigates metastasis-induced osteolysis superior to systemic administration
by: Anas Nooh, et al.
Published: (2017-03-01)

Anti-Tumor Effects of Low Dose Zoledronate on Lung Cancer-Induced Spine Metastasis
by: Elie Akoury, et al.
Published: (2019-08-01)

Prognostic value of inflammation-based scores in patients receiving radical resection for colorectal cancer
by: Fang Wang, et al.
Published: (2018-11-01)

EFFECT OF ZOLEDRONIC AND IBANDRONIC ACIDS ON BONE METABOLISM IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS
by: O V Yakushevskaya, et al.
Published: (2012-08-01)

Protection of bone in premenopausal women with breast cancer: focus on zoledronic acid
by: Aft R
Published: (2012-10-01)

Development of 166Ho-zoledronate as a bone marrow ablative agent
by: Mirsaeed Nikzad, et al.
Published: (2016-02-01)

Effect of zoledronic acid injection combined with radiopharmaceutical 89SrCI2 therapy on the growth and clinical symptoms of lung cancer bone metastasis
by: Jia-Lun Zhu, et al.
Published: (2016-09-01)

Previous Use of Anti-Vascular Endothelial Growth Factor Receptor Agents Decreases Efficacy of Fruquintinib in Metastatic Colorectal Cancer Refractory to Standard Therapies
by: Lei Wang, et al.
Published: (2020-11-01)

Optimal Surgery Type and Adjuvant Therapy for T1N0M0 Lung Large Cell Neuroendocrine Carcinoma
by: Kunwei Peng, et al.
Published: (2021-03-01)

Effect of Systemic Zoledronic Acid Dosing Regimens on Bone Regeneration in Osteoporotic Rats
by: Marwa Y. Shaheen, et al.
Published: (2021-02-01)

Zoledronic acid: clinical utility and patient considerations in osteoporosis and low bone mass
by: Ronald C Hamdy
Published: (2010-11-01)

Once-yearly zoledronic acid in the prevention of osteoporotic bone fractures in postmenopausal women
by: Irene Lambrinoudaki, et al.
Published: (2008-09-01)

Short-Term Zoledronic Acid Reduces Trabecular Bone Remodeling In Aged Dogs
by: Helm, Nathan B.
Published: (2010)

Examining zoledronic acid for the prevention of bone loss in patients receiving bariatric surgery
by: Yi Liu, et al.
Published: (2021-06-01)

A Case of Metastatic Collecting Duct Carcinoma Whose Massive Skull Bone Metastasis was Prominently Reossified by Gemcitabine Plus Cisplatin Chemotherapy Combined with Zoledronic Acid
by: Makoto Kawaguchi, et al.
Published: (2017-11-01)

Comparison of denosumab and zoledronic acid for the treatment of solid tumors and multiple myeloma with bone metastasis: a systematic review and meta-analysis based on randomized controlled trials
by: Lianghai Jiang, et al.
Published: (2021-06-01)

Study on Zoledronic Acid Reducing Acute Bone Loss and Fracture Rates in Elderly Postoperative Patients with Intertrochanteric Fractures
by: Zhong Liu, et al.
Published: (2019-06-01)

Oestrogen and zoledronic acid driven changes to the bone and immune environments: Potential mechanisms underlying the differential anti-tumour effects of zoledronic acid in pre- and post-menopausal conditions
by: Christopher N. George, et al.
Published: (2020-12-01)

EFFICACY OF ZOLEDRONIC ACID IN THE PREVENTION OF BONE METASTASES IN PATIENTS WITH LOCALLY ADVANCED PROSTATE CANCER
by: T. N. Musaev, et al.
Published: (2014-07-01)

Combination of Melatonin and Zoledronic Acid Suppressed the Giant Cell Tumor of Bone in vitro and in vivo
by: Xudong Wang, et al.
Published: (2021-08-01)

Comparison of Denosumab and Zoledronic acid as neoadjuvant therapy in patients with giant cell tumor of bone
by: Himanshu Kanwat, et al.
Published: (2021-07-01)

Preoperative zoledronic acid therapy prevent hungry bone syndrome in patients with primary hyperparathyroidism
by: Sabaretnam Mayilvaganan, et al.
Published: (2017-01-01)

Response to zoledronic acid in patients with active Paget's disease of bone: A retrospective study
by: Harsh Durgia, et al.
Published: (2019-01-01)

Cannot write session to /tmp/vufind_sessions/sess_js6ga3kjhv8jogf3v7fejmeoct